The estimation of risk for atherosclerotic and cardiovascular events based only on the presence of classical risk factors is often insufficient. Therefore, efforts have been made to find markers that indicate the presence of preclinical disease in individual subjects like blood markers of atherosclerosis and preclinical deterioration of the arterial wall.
No takes yet. Share an insight, caveat, or question.
Pavel Poredoš (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: